We report our progress in understanding the structure-function relationship
of the interaction between protein inhibitors and several serine proteases
. Recently, we have determined high resolution solution structures of two i
nhibitors Apis mellifera chymotrypsin inhibitor-1 (AMCI-I) and Linum usitat
issimum trypsin inhibitor (LUTI) in the free state and an ultra high resolu
tion X-ray structure of BPTI. All three inhibitors, despite totally differe
nt scaffolds, contain a solvent exposed loop of similar conformation which
is highly complementary to the enzyme active site. Isothermal calorimetry d
ata show that the interaction between wild type BPTI and chymotrypsin is en
tropy driven and that the enthalpy component opposes complex formation. Our
research is focused on extensive mutagenesis of the four positions from th
e protease binding loop of BPTI: P-1, P-1', P-3, and P-4. We mutated these
residues to different amino acids and the variants were characterized by de
termination of the association constants, stability parameters and crystal
structures of protease-inhibitor complexes. Accommodation of the P-1 residu
e in the S-1 pocket of four proteases: chymotrypsin, trypsin, neutrophil el
astase and cathepsin G was probed with 18 P-1 variants. High resolution X-r
ay structures of ten complexes between bovine trypsin and P-1 variants of B
PTI have been determined and compared with the cognate P-1 Lys side chain.
Mutations of the wild type Ala16 (P-1') to larger side chains always caused
a drop of the association constant. According to the crystal structure of
the Leu16 BPTI-trypsin complex, introduction of the larger residue at the P
-1' position leads to steric conflicts in the vicinity of the mutation. Fin
ally, mutations at the P-4 site allowed an improvement of the association w
ith several serine proteases involved in blood clotting. Conversely, introd
uction of Ser, Val, and Phe in place of Gly12 (P-4) had invariably a destab
ilizing effect on the complex with these proteases.